High incidence of post-transplant lymphoproliferative disorder in the last two years, after allogeneic stem cell transplantation with thymoglobulin-based conditioning

被引：0
|
作者：
Yanez, L. [1 ]
Gonzales, M. [1 ]
Cuaresma, E. [1 ]
Bermudez, A. [1 ]
Richard, C. [1 ]
Conde, E. [1 ]
Insunza, A. [1 ]
机构：
[1] Hosp Marques de Valdecilla, Santander, Spain
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S344 / S345
页数：2
相关论文
共 50 条
  • [1] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN SKELETAL MUSCLE ARISING SEVEN YEARS AFTER ALLOGENEIC STEM CELL TRANSPLANT
    Powell, Alice
    Sy, Joanne
    Barnett, Yael
    Mosalski, Simon
    Brew, Bruce
    Fay, Keith
    Tomlinson, Susan
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E15 - E16
  • [2] Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation
    Kalra, Amit
    Roessner, Cameron
    Jupp, Jennifer
    Williamson, Tyler
    Tellier, Raymond
    Chaudhry, Ahsan
    Khan, Faisal
    Taparia, Minakshi
    Jimenez-Zepeda, Victor H.
    Stewart, Douglas A.
    Daly, Andrew
    Storek, Jan
    CLINICAL TRANSPLANTATION, 2018, 32 (01)
  • [3] Rituximab in treatment of post-transplant lymphoproliferative disease after allogeneic stem cell transplantation
    Gil, Lidia
    Styczynski, Jan
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2011, 15 (03): : 155 - 158
  • [4] Post-transplant lymphoproliferative disease (PTLD): high incidence after non-T-cell-depleted allogeneic stem cell transplantation
    Juvonen, E
    Aalto, S
    Volin, L
    Ruutu, T
    Tarkkanen, J
    Piiparinen, H
    Hedman, K
    BONE MARROW TRANSPLANTATION, 2002, 29 : S27 - S28
  • [5] EBV-associated post-transplant lymphoproliferative disorder after pediatric allogeneic hematopoietic stem cell transplantation
    Yoo, Keen Hee
    Kim, Hee-Jin
    Ki, Chang Seok
    Sung, Ki Woong
    Jung, Hye Lim
    Ko, Youn Hyeh
    Koo, Hong-Hoe
    BLOOD, 2007, 110 (11) : 322B - 322B
  • [6] Post-transplant lymphoproliferative disorder following non-myeloablative allogeneic stem cell transplantation
    Snyder, MJ
    Stenzel, TT
    Lagoo, AS
    Rizzieri, DA
    Chao, N
    Buckley, PJ
    Gong, JZ
    MODERN PATHOLOGY, 2003, 16 (01) : 253A - 253A
  • [7] Post-transplant lymphoproliferative disorder following non-myeloablative allogeneic stem cell transplantation
    Snyder, MJ
    Stenzel, TT
    Lagoo, AS
    Rizzieri, DA
    Chao, N
    Buckley, PJ
    Gong, JZ
    LABORATORY INVESTIGATION, 2003, 83 (01) : 253A - 253A
  • [8] Post-transplant lymphoproliferative disorder of the adrenal gland after allogeneic hematopoietic stem cell transplantation: report of two cases and literature review
    Kasahara, H.
    Mori, T.
    Kato, J.
    Koda, Y.
    Kohashi, S.
    Kikuchi, T.
    Sakurai, M.
    Yamane, Y.
    Mikami, S.
    Kameyama, K.
    Takahashi, Y.
    Okamoto, S.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (06) : 909 - 914
  • [9] Burden of Post-Transplant Lymphoproliferative Disorder-Mortality After Allogeneic Hematopoietic Cell Transplantation
    Katz, Aaron
    Barlev, Arie
    Joshi, A. J.
    BONE MARROW TRANSPLANTATION, 2018, 53 : 305 - 306
  • [10] Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report
    Tugend, Margaret
    Dattero, Jordan
    Shore, Tsiporah
    Korobeynikov, Vladislav
    Sekula Jr, Raymond F.
    FRONTIERS IN ONCOLOGY, 2024, 14
12345